PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA.\', \'Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.\', \'Department of Neurology, University of California, San Francisco, San Francisco, California, USA.\', \'Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA.\', \'Department of Medicine, University of California, San Francisco, San Francisco, California, USA.\', \'Chan Zuckerberg Biohub, San Francisco, California, USA.\', \'Department of Medicine, Stanford University Medical School, Stanford, California, USA.\', \'Department of Microbiology and Immunology, Stanford University Medical School, Stanford, California, USA.\', \'Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA jim.wells@ucsf.edu.\', \'Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00802-2010.1128/mSphere.00802-20
?:doi
?:hasPublicationType
?:journal
  • mSphere
is ?:pmid of
?:pmid
?:pmid
  • 32938700
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.03
?:rankingScore_hIndex
  • 12
is ?:relation_isRelatedTo_publication of
?:title
  • Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all